Cargando…
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
Colorectal cancer continues to be an important public health concern, despite improvements in screening and better systemic chemotherapy. The integration of targeted therapies in the treatment of colon cancer has resulted in significant improvements in efficacy outcomes. Angiogenesis is important fo...
Autores principales: | Puthillath, Ajithkumar, Patel, Anush, Fakih, Marwan G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886334/ https://www.ncbi.nlm.nih.gov/pubmed/20616890 |
Ejemplares similares
-
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
por: Escudier, Bernard, et al.
Publicado: (2008) -
Role of bevacizumab therapy in the management of glioblastoma
por: Peak, Scott J, et al.
Publicado: (2010) -
Targeting KRAS(G12C)-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
por: Ji, Jingran, et al.
Publicado: (2022) -
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
por: Tella, Sri Harsha, et al.
Publicado: (2022) -
Integrating Academic and Community Practices in the Management of Colorectal Cancer: The City of Hope Model
por: Karimi, Misagh, et al.
Publicado: (2020)